Gyre Therapeutics (GYRE) Cash from Operations Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -32.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.53% |
| Dec 31, 2025 | -28.71% |
| Sep 30, 2025 | 38.07% |
| Jun 30, 2025 | 29.53% |
| Mar 31, 2025 | 77.96% |
| Dec 31, 2024 | 46.16% |
| Sep 30, 2024 | 27.65% |
| Jun 30, 2024 | 35.13% |
| Mar 31, 2024 | 28.43% |
| Dec 31, 2023 | 29.11% |
| Sep 30, 2023 | 37.20% |
| Jun 30, 2023 | 31.99% |
| Mar 31, 2023 | 61.02% |
| Dec 31, 2022 | 93.36% |
| Sep 30, 2022 | 7.18% |
| Jun 30, 2022 | -2.35% |
| Mar 31, 2022 | 6.95% |
| Dec 31, 2021 | -25.18% |
| Sep 30, 2021 | -45.43% |
| Jun 30, 2021 | -39.50% |
| Mar 31, 2021 | -68.32% |
| Dec 31, 2020 | -51.84% |
| Sep 30, 2020 | -38.19% |
| Jun 30, 2020 | -50.93% |
| Mar 31, 2020 | -3.73% |
| Dec 31, 2019 | -17.57% |
| Sep 30, 2019 | -21.22% |
| Jun 30, 2019 | -46.56% |
| Mar 31, 2019 | -46.64% |
| Dec 31, 2018 | -20.56% |
| Sep 30, 2018 | 9.99% |
| Jun 30, 2018 | -75.69% |
| Mar 31, 2018 | -19.67% |
| Dec 31, 2017 | -45.31% |
| Sep 30, 2017 | -31.11% |
| Jun 30, 2017 | 20.95% |
| Mar 31, 2017 | 33.88% |
| Dec 31, 2016 | -30.35% |
| Sep 30, 2016 | 19.27% |
| Jun 30, 2016 | 29.55% |
| Mar 31, 2016 | 20.16% |
| Dec 31, 2015 | 23.75% |
| Sep 30, 2015 | 2.54% |
| Jun 30, 2015 | 57.12% |
| Mar 31, 2015 | 50.72% |
| Dec 31, 2014 | 53.54% |
| Sep 30, 2014 | 45.41% |
| Jun 30, 2014 | 27.16% |
| Mar 31, 2014 | 12.35% |
| Dec 31, 2013 | 51.46% |
| Sep 30, 2013 | 17.01% |